Quorum Review IRB Re-Designs Web Site
Seattle-based IRB Quorum Review launched its redesigned Web site, which the company says features better navigation and improved usability. These features include site wide Google-search, improved navigation bars on each Web page, and expanded content.
The Web site guides researchers through the steps of the ethics review process with background information, links to all applicable forms, and sets of Frequently Asked Questions. Users also can find information on Quorum's service offerings, such as the review of publicly-funded studies, exemption determinations, in-house translations, working with institutions, pre-review services and training.
Quorum Review is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
